Want to know more about the 2019 MCS Master Classes?
Visit our 2019 MCS Master Class page for schedules, programs, registration information and more.

Want to know more about the 2019 MCS Master Classes?
Visit our 2019 MCS Master Class page for schedules, programs, registration information and more.

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: PH, PHARM

Chairs: Bastian Smack, MD and Brent Lampert, MD
 

10:30 AM	(19) Right Ventricular Strain as a Predictor of Post-LVAD Early Right Ventricular Failure L. W. Liang, E. Y. Birati, C. Justice, Y. Han. Hospital of the University of Pennsylvania, Philadelphia, PA
10:45 AM	(20) Serial Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure after Left Ventricular Assist Device Implantation M. H. Gonzalez1, J. Wagener1, A. Aggarwal2, T. Buda1, V. Menon1, M. Jacob1, W. Tang1, E. Hsich1, M. Tong3, E. Soltesz3, R. Starling1, J. Estep1, E. Joyce1. 1Cardiology, Cleveland Clinic Foundation, Cleveland, OH, 2Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 3Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, OH
11:00 AM	(21) Bridging Biventricular Failure to Successful Heart Transplants: HVAD BiVAD versus TAH A. Salimbangon1, R. Chand1, C. Lum1, D. Vucicevic2, E. DePasquale1. 1UCLA, Los Angeles, CA, 2Newark Beth Israel, Newark, NJ
11:15 AM	(22) New Insights into Right Ventricular Function among Patients with Left Ventricular Assist Devices Using High Fidelity Conductance Catheters to Generate Real Time Pressure Volume Loops W. K. Cornwell1, G. Coe2, A. Levy2, T. Tran2, M. Bradley2, K. O'Gean2, M. Ostertag2, M. Spotts3, S. Laing2, J. Lawley4, C. DeSouza5, B. Stauffer2, A. Ambardekar2, J. Pal2, G. Wolfel2, W. Kohrt2. 1University of Colorado, Denver, CO, 2University of Colorado, Aurora, CO, 3Aurora, University of Colorado, Denver, CO, 4University of Innsbruck, Innsbruck, Austria, 5University of Colorado, Boulder, CO
11:30 AM	(23) Early and Late Right Heart Failure Following LVAD Implantation: Epidemiology, Natural History and Outcomes. An Analysis of the STS INTERMACS Database C. J. Kapelios1, L. H. Lund2, C. H. Selzman3, S. L. Meyers4, A. Koliopoulou3, J. Stehlik3, O. Wever-Pinzon3, A. G. Kfoury5, J. C. Fang3, J. K. Kirklin4, S. G. Drakos3. 1National and Kapodestrian University of Athens, Athens, Greece, 2Karolinska University Hospital, Stockholm, Sweden, 3University of Utah Health & School of Medicine, Salt Lake City, UT, 4Kirklin Institute for Research in Surgical Outcomes, University of Alabama at Birmingham, Birmingham, AL, 5Intermountain Medical Center, Salt Lake City, UT
11:45 AM	(24) Pectoralis Muscle Attenuation Improves the Prediction of Right Ventricular Failure after LVAD Implantation H. Shah1, T. Murray2, J. Estep3, R. Araujo4, A. El Rafei5, B. Trachtenberg4, L. Teigen6, J. Schultz1, R. John7, C. Martin1, R. Cogswell1. 1Cardiology, University of Minnesota, Minneapolis, MN, 2Biostatistics, University of Minnesota, Minneapolis, MN, 3Cardiology, Cleveland Clinic, Cleveland, OH, 4Cardiology, Houston Methodist, Houston, TX, 5Internal Medicine, University of Minnesota, Minneapolis, MN, 6Gastroenterology Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, 7Cardiothoracic Surgery, University of Minnesota, Minneapolis, MN
12:00 PM	(25) Oral Milrinone for the Treatment of Right Ventricular Failure in LVAD Patients N. Uriel1, D. Burkhoff2, G. Kim1, T. Silverstein1, J. Raikhelkar1, B. Smith1, C. Juricek1, V. Jeevanandam1, R. M. Lang3, G. Sayer1. 1University of Chicago, Chicago, IL, 2Columbia University, New York, NY, 3University of Chicago Medicine, Chicago, IL

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS

Session Summary: The ISHLT 2018 Annual Meeting included the highest number of abstracts on less invasive VAD implantation approach. This symposium will evaluate the potential advantages of minimal invasive approaches for VAD implantation, the usage of ECMO instead of CPB, and the feasibility and advantages of adding minimal invasive and off-pump techniques.

Chairs: George M. Wieselthaler, MD and Marian Urban, MD
 

10:30 AM	Influence of the Surgical Technique on Post-Operative Outcome: Is Minimal Invasive Approach the Way to Go? Victor Pretorius, MD, UCSD Medical Center, San Diego, CA, USA
10:45 AM	Q&A
10:50 AM	The Alternative Approach: Should We Be Using ECMO Instead of CPB? Julia Riebandt, MD, Medical University of Vienna, Vienna, Austria
11:05 AM	Q&A
11:10 AM	Going ‘Off-Pump’: Does It Make a Difference? Diyar Saeed, MD, PhD, Leipzig Heart Center, Leipzig, Germany
11:25 AM	Q&A
11:30 AM	Going ‘BIVAD’: Acute Pitfalls and Long-Term Threats Evgenij V. Potapov, MD, PhD, Deutsches Herzzentrum, Berlin, Germany
11:45 AM	Q&A
11:50 AM	Out with the Old: Pump Replacement/Upgrade Decommissioning Explant Carmelo A. Milano, MD, Duke University Medical Center, Durham, NC, USA
12:05 PM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Maria M. Mountis, DO and Christopher T. Salerno, MD
 

2:00 PM	(52) Outcomes of Patients Supported with ECMO as a Bridge to Durable Mechanical Circulatory Support: An Analysis of the STS Intermacs Database R. Y. Loyaga-Rendon1, T. Boeve2, J. Tallaj3, S. Lee1, M. Leacche2, D. A. Koehl4, R. S. Cantor4, K. Lotun5, D. Acharya5. 1Cardiology Division, Spectrum Health, Grand Rapids, MI, 2Cardiothoracic Surgery Division, Spectrum Health, Grand Rapids, MI, 3Cardiovascular Division, University of Alabama at Birmingham, Birmingham, AL, 4Kirklin Institute for Research in Surgical Outcomes, University of Alabama at Birmingham, Birmingham, AL, 5Cardiovascular Diseases Division, University of Arizona Sarver Heart Center, Tucson, AZ
2:15 PM	(53) Comparison of ECMO Patients Bridged to LVAD vs Bridged to Transplantation C. Lui, C. D. Fraser, A. Suarez-Pierre, X. Zhou, K. J. Zehr, C. W. Choi, A. Kilic. Johns Hopkins University, Baltimore, MD
2:30 PM	(54) Short and Long-Term Adverse Events in Patients on Temporary Circulatory Support before LVAD: An IMACS Registry Analysis V. Ton1, J. A. Hernandez-Montfort2, R. Xie3, B. P. Meyns4, T. Nakatani5, M. Yanase6, S. Shaw7, S. Pettit8, I. Netuka9, J. Kirklin10, D. J. Goldstein11, J. Cowger12. 1University of Maryland School of Medicine, Baltimore, MD, 2The University of Texas Medical Branch-Galveston, Galveston, TX, 3The University of Alabama at Birmingham, Birmingham, AL, 4Gasthuisberg University Hopital, Leuven, Belgium, 5National Cardiovascilar Center, Osaka, Japan, 6National Cerebral and Cardiovascular Center, Osaka, Japan, 7Wythenshawe Hospital, Manchester, United Kingdom, 8Royal Papworth Hospital, Cambridge, United Kingdom, 9IKEM - Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 10University of Alabama at Birmingham, Birmingham, AL, 11Montefiore Medical Center, New York, NY, 12Henry Ford Health System, Detroit, MI
2:45 PM	(55) Longitudinal Impact of Temporary Mechanical Circulatory Support on Durable Left Ventricular Assist Device Outcomes: An IMACS Registry Analysis J. A. Hernandez-Montfort1, V. Khue Ton2, R. Xie3, A. Fisher4, B. Meyns5, T. Nakatani6, I. Netuka7, S. Pettit8, S. Shaw9, M. Yanase10, J. K. Kirklin11, A. Rowe12, D. J. Goldstein13, J. Cowger14. 1The University of Texas Medical Branch - Galveston, Galveston, TX, 2University of Maryland, Baltimore, MD, 3IMACS, Birmingham, AL, 4Newcastle University, Newcastle, United Kingdom, 5UZ Leuven, Leuven, Belgium, 6Maki Hospital, Osaka, Japan, 7Institut Clinical and Experimental Medicine, Prague, Czech Republic, 8Papworth, Cambridge, United Kingdom, 9Manchester University NHS Foundation Trust, Manchester, United Kingdom, 10National Cerebral and Cardiovascular Center, Osaka, Japan, 11University of Alabama- Birmingham, Birmingham, AL, 12ISHLT Headquarters, Addison, TX, 13Montefiore, Bronx, NY, 14Cardiology, Henry Ford Hospital, Detroit, MI
3:00 PM	(56) Transition from Short-Term to Durable Mechanical Circulatory Support Systems. Outcome and Patient Selection. On Behalf of ECMO-VAD Study Group D. Saeed1, E. Potapov2, A. Loforte3, M. Morchius4, D. Schibilsky5, D. Zimpfer6, J. Riebandt6, F. Pappalardo7, M. Attisani8, A. Haneya9, F. Ramjankhan10, D. Donker10, U. Jorde11, R. Wieloch1, R. Ayala12, D. Tsyganenko2, J. Cremer9, A. Lichtenberg1, J. Gummert4. 1Cardiovascular Surgery, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany, 2Deutsches Herzzentrum Berlin, Berlin, Germany, 3Bologna University, Bologna, Italy, 4Herz und Diabetes Zentrum NRW, Bad Oeynhausen, Germany, 5Cardiovascular Surgery, Freiburg University, Freiburg, Germany, 6Medical University Vienna, Vienna, Austria, 7Cardiovascular Surgery, San Raffaele Hospital, Milan, Italy, 8Cardiovascular Surgery, University of Turin, Turin, Italy, 9Cardiovascular Surgery, University Hospital Schleswig Holstein, Kiel, Germany, 10Cardiovascular Surgery, University Medical Center Utrecht, Utrecht, Netherlands, 11Montefiore Medical Center, Bronx, NY, 12Freiburg University, Freiburg, Germany
3:15 PM	(57) Risk Factors for Bleeding and Thrombosis Events on Veno-Arterial Extracorporeal Life Support: An ELSO Analysis F. R. Cabezas1, E. W. Grandin1, R. Kociol1, M. R. Mehra2. 1Beth Israel Deaconess Medical Center, Boston, MA, 2Advanced Heart Failure, Brigham and Women's Hospital, Boston, MA
3:30 PM	(58) Impact of Temporary Mechanical Circulatory Support Prior to Implantation of a Ventricular Assist Device with a Follow-Up of 1 Year- A EUROMACS Analysis D. Schibilsky1, T. de By2, J. Gummert3, F. Ramjankhan4, J. Wolfinger1, E. Potapov5, I. Netuka6, F. Beyersdorf1, M. Siepe1. 1Department of Cardiovascular Surgery, University Heart Center Freiburg, Bad Krozingen, Freiburg Germany and Medical Faculty of the Albert-Ludwigs-University Freiburg, Germany, Freiburg, Germany, 2EUROMACS, Windsor, Germany, 3Department of Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany, 4Department of Cardiovascular Surgery, University Medical Center Utrecht, Utrecht, Germany, 5Department of Cardiothoracic and Vascular Surgery, German Heart Institute Berlin, Berlin, Germany, 6Department of Cardiac Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS

Session Summary: CF-LVAD patients are living longer, and cardiac implantable electronic devices and arrhythmia management have assumed a significant role. More data is available to guide management, and expert speakers including MCS & EP specialists will discuss existing data and provide recommendations regarding appropriate management of ICD/CRT and arrhythmias in LVAD recipients.

Chairs: Michael M. Givertz, MD and Stephan Schueler, MD, PhD, FRCS
 

2:00 PM	Atrial Fibrillation and Flutter in LVAD Patients: Incidence, Significance and Management Sean P. Pinney, MD, Mount Sinai Medical Center, New York, NY, USA
2:15 PM	Q&A
2:20 PM	Optimal Device Programming and Role of Catheter and Surgical Ablation in Arrhythmia Management Post-LVAD Joshua D. Moss, MD, UCSF Medical Center, San Francisco, CA, USA
2:35 PM	Q&A
2:40 PM	DEBATE: All VAD Patients Should Have ICD and All VT Should Be Ablated (PRO) Anique Ducharme, MD, MSC, Montreal Heart Institute, Montreal, QC, Canada
2:55 PM	DEBATE: All VAD Patients Should Have ICD and All VT Should Be Ablated (CON) Shashank S. Desai, MD, Inova Fairfax Hospital, Falls Church, VA, USA
3:10 PM	DEBATE: BiV Pacing Improves Outcomes in LVAD Patients (PRO) Gabriel Sayer, MD, University of Chicago, Chicago, IL, USA
3:25 PM	DEBATE: BiV Pacing Improves Outcomes in LVAD Patients (CON) Jens Garbade, MD, University of Leipzig Medical Center, Leipzig, Germany

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: NHSAH

Chairs: Melana Yuzefpolskaya, MD and Joseph Rogers, MD
 

4:15 PM	(86) Atrial Fibrillation is a Predictor of Poor Physical Capacity 6 Months after Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis from ELEVATE K. K. Mirza1, F. Gustafsson1, Y. Pya2, S. Shaw3, A. Diegeler1, I. Netuka4, J. Lavee5, J. Garbade6, M. Morshuis7, J. Heatley8, D. Saeed9, E. V. Potapov10, J. Schmitto11, D. Zimpfer12. 1Department of Cardiology, Rigshospitalet, Copenhagen, Denmark, 2National Research Center for Cardiac Surgery, Astana, Kazakhstan, 3Southmoor Road, M23 9LT, Manchester University NHS Foundation Trust, Manchester, United Kingdom, 4Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 5Heart Transplantation Unit, Leviev Heart Center, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 6Struempellstr. 39, 4289, Department of Cardiac Surgery, Heart Center Leipzig, University of Leipzig, Leipzig, Germany, 7Georgstrasse 11, 32545, Department of Cardiothoracic Surgery, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany, 8Abbott, Chicago, IL, 9Strümpellstrasse 39, 04289, University Department for Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany, 10Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany, 11Department of Cardiothoracic, Transplantation and Vascular Surgery, Medizinische Hochschule Hannover, Hannover, Germany, 12Department of Surgery, Waehringer Guertel 18–20, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
4:30 PM	(87) Impact of Atrial Fibrillation on Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation V. Blumer1, M. Ortiz2, G. Hernandez3, A. Gage4, E. Joyce5, S. Chaparro1. 1University of Miami, Miami, FL, 2University of Iowa, Io, IA, 3Univ. of Miami, Miami, FL, 4Cleveland Clinic, Cleveland, OH, 5Mater Misericordiae University Hospital, Dublin, Ireland
4:45 PM	(88) Peak Left Atrial Appendage Emptying Velocity Remains Reduced in Atrial Fibrillation during Continuous Flow Left Ventricular Assist Device Support A. Rahman1, E. Tam1, L. ZHeng1, J. Fontes1, S. Forest2, S. Vukelic1, D. Sims1, J. Shin1, S. Patel1, D. J. Goldstein2, U. P. Jorde1, O. Saeed1. 1Medicine (Cardiology), Montefiore Medical Center, Bronx, NY, 2Cardiothoracic Surgery, Montefiore Medical Center, Bronx, NY
5:00 PM	(89) Comparison of Amiodarone and Beta Blockers to Suppress Tachyarrhythmias in Patients with Left Ventricular Assist Devices B. El-Sabawi1, J. V. Hull2, H. Tun3, A. S. Vaidya3, J. E. Rahman3, K. Pandya3, L. Grazette3, M. W. Fong3. 1Department of Medicine, Mayo Clinic, Rochester, MN, 2Keck School of Medicine of the University of Southern California, Los Angeles, CA, 3Division of Cardiology, Keck School of Medicine of the University of Southern California, Los Angeles, CA
5:15 PM	(90) Functional Status, Quality of Life and Ventricular Tachyarrhythmias Improve with Right Ventricular Pacing Compared to Biventricular Pacing in LVAD Patients B. Chung1, J. Grinstein2, S. Weatherford1, S. Tayazime1, D. Rodgers1, A. Nguyen1, N. Narang1, G. Kim1, J. Raikhelkar1, U. Jorde3, C. LaBuhn1, V. Jeevanandam1, G. Sayer1, N. Uriel1. 1University of Chicago, Chicago, IL, 2MedStar Health, Washington, DC, DC, 3Montefiore Medical Center, New York City, NY
5:30 PM	(91) Acute Hemodynamic Effects of Different Pacing Strategies in LVAD Recipients G. Gulati1, M. Brisco-Bacik2, C. Madias1, S. Joseph3, A. Kilic4, J. Rich5, I. Gosev6, M. Kiernan1. 1Cardiology, Tufts Medical Center, Boston, MA, 2Cardiology, Temple University Hospital, Philadelphia, PA, 3Cardiology, Baylor University Medical Center, Dallas, TX, 4Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, 5Cardiology, Northwestern University, Chicago, IL, 6Surgery, University of Rochester, Rochester, NY
5:45 PM	(92) Ventricular Arrhythmias in Patients with Biventricular Assist Devices A. Lin, H. Tran, J. Hsu, K. Hoffmayer, G. Feld, E. Adler, V. Pretorius, D. Krummen, G. Ho. University of California San Diego, San Diego, CA

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS
Secondary Audience: HF/HTX

Session Summary: This symposium will focus on short term mechanical support with a view to optimizing results, whether as a bridge to recovery, long term mechanical support or transplant. Current and future management trends will be discussed to identify best practices for these complex patients.

Chairs: Bart Meyns, MD, PhD and Luciano Potena, MD, PhD
 

4:15 PM	IABPs Work, But in Whom? Jerry D. Estep, MD, Cleveland Clinic, Cleveland, OH, USA
4:30 PM	Q&A
4:35 PM	In It for the Long Haul? What is the Role of ECMO in Short-Term Support? Martin Strueber, MD, Newark Beth Israel Medical Center, Newark, NJ, USA
4:50 PM	Q&A
4:55 PM	DEBATE: Six Months After the Change in the US Allocation System: It Still Makes Sense to Transplant Patients Off ECMO (PRO) Danny Ramzy, MD, PhD, Cedars-Sinai Med Ctr, Los Angeles, CA, USA
5:10 PM	DEBATE: Six Months After the Change in the US Allocation System: It Still Makes Sense to Transplant Patients Off ECMO (CON) Jose Gonzalez-Costello, MD, Belvitge Hospital, Barcelona, Spain
5:25 PM	Debate Rebuttal (PRO) - Danny Ramzy, MD, PhD
5:30 PM	Debate Rebuttal (CON) - Jose Gonzalez-Costello, MD
5:35 PM	Do All Roads Lead to Rome? Access Strategies for Temporary Percutaneous Mechanical Support Jennifer A. Cowger, MD, MS, Henry Ford Hospitals, Detroit, MI, USA
5:50 PM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Junior Faculty Clinical Case Reports: Mechanical Circulatory Support (Banda Sea 1)
(MCS)   Poster Numbers: 1245-1264
 

---

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Junior Faculty Clinical Case Reports: Mechanical Circulatory Support (Banda Sea 2)
(MCS)   Poster Numbers: 1265-1280

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Paolo C. Colombo, MD and Anique Ducharme, MD, MSC
 

6:15 PM	(393) Pulmonary Effective Arterial Elastance and Pulmonary Artery Capacitance after Left Ventricular Assist Device Implantation is Associated with Hemocompatibility-Related Adverse Events D. Nitta, T. Imamura, T. Fujino, A. Nguyen, B. Chung, D. Rodgers, J. Raikhelkar, B. Smith, L. Holzhauser, N. Narang, I. Ebong, C. Juricek, V. Jeevanandam, G. Kim, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
6:20 PM	(394) Decoupling between Pulmonary Artery and Wedge Pressure is Associated with Hemocompatibility-Related Adverse Events Following LVAD Implantation T. Imamura, S. Kalantari, B. Smith, D. Rodgers, J. Raikhelkar, G. Kim, A. Nguyen, N. Narang, B. Chung, I. Ebong, L. Holzhauser, D. Nitta, T. Fujino, C. Juricek, P. Combs, D. Onsager, T. Song, T. Ota, V. Jeevanandam, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
6:25 PM	(396) Hemocompatibility-Related Adverse Events: Is the Burden Different among Available Centrifugal Flow Pumps? K. A. Holst1, M. P. Weber2, V. Tchantchaleishvili2, S. Dunlay1, S. Maltais1, R. Daly1, J. Stulak1. 1Mayo Clinic, Rochester, MN, 2Thomas Jefferson University, Philadelphia, PA
6:30 PM	(397) Digoxin is Associated with Decreased Survival Free from Hemocompatibility-Related Adverse Events in LVAD Patients - A Propensity Score Matched Analysis A. Pinsino1, A. Gaudig2, K. L. Hoffman3, D. D'Angelo3, E. A. Royzman2, G. M. Mondellini2, F. Castagna2, A. M. Zuver2, A. R. Garan2, H. Takayama4, K. Takeda4, Y. Naka4, R. T. Demmer5, M. Yuzefpolskaya2, P. C. Colombo2. 1Jacobi - Albert Einstein College of Medicine, Bronx, NY, 2Department of Medicine, Columbia University Medical Center, New York, NY, 3Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, 4Department of Surgery, Columbia University Medical Center, New York, NY, 5Epidemiology and Community Health, University of Minnesota, Minneapolis, MN
6:35 PM	(398) Influence of Device Type on Stroke Risk in Women Undergoing LVAD Implantation R. J. Vela1, J. Pruszynski1, A. Amin2, M. Drazner2, L. C. Huffman1, M. Peltz1. 1Cardiovascular & Thoracic Surgery, UT Southwestern Medical Center, Dallas, TX, 2Internal Medicine, UT Southwestern Medical Center, Dallas, TX
6:40 PM	(399) Concentrated Factor Administration and Subsequent Stroke Rates on HeartMate II LVAD Support J. Schultz1, A. Shaffer2, J. Misialek1, H. Shah1, R. John2, C. Martin1, T. Thenappan1, T. Alexy1, F. Kamdar1, R. Cogswell1. 1Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, MN, 2Department of Surgery, Division of Cardiovascular Surgery, University of Minnesota, Minneapolis, MN
6:45 PM	(400) Current Smoking and Increased Risk of Stroke in Patients with Left Ventricular Assist Device S. Sherazi1, I. Goldenberg1, S. McNitt1, V. Kutyifa1, I. Gosev2, K. Wood2, L. Chen1, S. Polonsky1, H. Vidula1, J. Alexis1. 1Cardiology, University of Rochester Medical Center, Rochester, NY, 2Cardiothoracic Surgery, University of Rochester Medical Center, Rochester, NY
6:50 PM	(401) Carotid Artery Blood Flow and Its Association with Stroke during Left Ventricular Assist Device Support M. E. Kiyatkin1, A. M. Zuver1, A. Gaudig2, M. Tiburcio1, B. J. McDonnell3, M. Yuzefpolskaya1, P. C. Colombo1, E. J. Stöhr4, J. Z. Willey1. 1Columbia University Irving Medical Center, New York, NY, 2University of Münster, Münster, Germany, 3Cardiff Metropolitan University, Cardif, United Kingdom, 4Cardiff Metropolitan University, Cardiff, United Kingdom
6:55 PM	(402) Different Risk Factors for Ischemic and Hemorrhagic Stroke on Continuous Flow Left Ventricular Assist Device Support H. K. Lamba1, M. Kim1, L. Hart1, B. Chou1, C. Rao1, S. Chatterjee1, S. Sattee2, F. Cheema1, A. Civitello1, R. Delgado1, A. Nair1, A. Shafii1, G. Loor1, T. Rosengart1, O. Frazier1, J. Morgan3. 1Division of Cardiothoracic Transplantation and Mechanical Circulatory Support, Texas Heart Institute at Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, TX, 3Texas Heart Institute at Baylor College of Medicine, Houston, TX
7:00 PM	(403) Strokes in LVADS. Insights from Modelling Flow in the Circle of Willis K. Balakrishnan1, R. Krishnakumar2, S. Krishna2. 1Fortis Malar Hospital, Chennai, India, 2Engineering Design, Indian Institute of Technology, Madras, Chennai, India
7:05 PM	(404) Does Left Atrial Appendage Occlusion in LVAD Patients Impact Outcomes: A Single Centre Study F. Yu1, J. Alvarez1, R. Ribeiro1, M. B. Adamson1, F. Amin1, M. Degen1, F. Foroutan2, J. Duero Posada2, T. Yau1, R. Cusimano1, F. Billia2, C. Alba2, M. Badiwala1, V. Rao1. 1Cardiovascular Surgery, Toronto General Hospital, Toronto, ON, Canada, 2Cardiology, Toronto General Hospital, Toronto, ON, Canada

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Hire Takayama, MD and Alastair Proudfoot, MBChB
 

6:15 PM	(405) Use of Extracorporeal Membrane Oxygenation (ECMO) in Acute Myocarditis - Insights from a National Inpatient Database M. S. Panhwar1, A. Karim1, M. Ginwalla2. 1Internal Medicine, Case Western Reserve Univ/Univ Hospitals of Cleveland, Cleveland, OH, 2Division of Cardiology, Case Western Reserve Univ/Univ Hospitals of Cleveland, Cleveland, OH
6:20 PM	(406) Assessing Left Ventricular Unloading and Wall Tension to Predict the Need for Durable Mechanical Circulatory Support after Peripheral VA-ECMO A. Prasad1, C. E. Brehm2, M. Goldenberg3, A. Ghodsizad4, M. M. Koerner5, A. El Banayosy5, K. Singbartl6. 1Anesthesiology and Perioperative Medicine, PennState Health, Hershey, PA, 2Heart and Vascular Institute, PennState Health, Hershey, PA, 3PennState College of Medicine, Hershey, PA, 4Miami Transplant Institute, University of Miami, Miami, FL, 5Advanced Cardiac Care and Transplant Institute, INTEGRIS Baptist Medical Center, Oklahoma City, OK, 6Critical Care Medicine, Mayo Clinic, Phoenix, AZ
6:25 PM	(407) Bridging VA ECMO to Durable MCS: Keys to Success A. M. El Banayosy, M. M. Koerner, D. A. Horstmanshof, A. Phancao, B. V. Jassman, C. Elkins, J. W. Long, A. El Banayosy. INTEGRIS Baptist Medical Center, Oklahoma City, OK
6:30 PM	(408) Hematological Complications of Impella as an Unloading Device in Patients with Cardiogenic Shock and Veno-Arterial ECMO. A Systematic Review and Metanalysis J. E. Pino1, E. Grajeda1, F. Ramos-Tuarez1, S. Sundaravel1, S. Sehatbakhsh2, E. Donath1, R. Chait2. 1Medicine, University of Miami/ JFK Medical Center, West Palm Beach, FL, 2Medicine, University of Miami/ JFK Medical Center, Atlantis, FL
6:35 PM	(409) Lactate Predicts Mortality 12 Hours after VA ECMO Initiation A. Melvin, B. C. Ayers, K. Wood, S. Prasad, B. Barrus, I. Gosev. University of Rochester, Rochester, NY
6:40 PM	(410) Prognostic Value of Neutrophil Lymphocyte Ratio for Early Renal Failure in ECMO Patients M. Sargin, M. T. Mete, S. B. Erdogan, H. Kuplay, M. Bastopcu, S. Akansel, M. Acarel, S. A. Aka. Cardiovascular Surgery, Siyami Ersek Hospital, Istanbul, Turkey
6:45 PM	(411) Differences in Post-Thoracotomy Outcomes in Patients Implanted off ECMO J. D. Schmitto1, M. Ozbaran2, C. Engin2, A. Simon3, V. Horvath4, J. Roussel5, M. Pac6, U. Kervan6, S. Klotz7, F. Wagner8, T. Schloeglhofer9, D. Zimpfer9. 1Cardiac Surgery, Hannover Medical School, Hannover, Germany, 2Cardiac Surgery, Ege University Medical Center, Izmir, Turkey, 3Cardiac Surgery, Royal Brompton and Harefield Hospital, London, United Kingdom, 4Cardiac Surgery, Center for Cardiovascular and Transplant Surgery, Brno, Czech Republic, 5Cardiac Surgery, University of Nantes, Nantes, France, 6Cardiac Surgery, Turkiye Yuksek Ihtisas Education & Research Hospital, Ankara, Turkey, 7Cardiac Surgery, University Hospital Luebeck, Luebeck, Germany, 8Cardiac Surgery, Uniklinik Hamburg Eppendorf, Hamburg, Germany, 9Cardiac Surgery, Medical University Vienna, Vienna, Austria
6:50 PM	(412) Mid Term Survival after VA ECMO Weaning A. Vincentelli1, N. Rousse1, V. Loobuyck1, M. Moussa2, A. Mugnier1, J. Soquet1, E. Robin2, F. Juthier1, C. Goeminne1, C. Banfi1. 1Cardiac Surgery, Centre Hospitalier Universitaire Regional de Lille, Lille, France, 2Cardiac Surgery, Anesthesiology, Centre Hospitalier Universitaire Regional de Lille, Lille, France
6:55 PM	(413) Does Transport Time or Distance from Hospital Affect Survival in Extracorporeal Membrane Oxygenation (ECMO) Patients? J. S. Nelson, A. Eisenbeiss, E. Stauder, K. Graham, R. Alharethi, W. Caine, H. Smith, B. Reid, M. McCulloch, B. Rasmusson, V. Hebl, B. Kfoury. Intermountain Medical Center, Murray, UT
7:00 PM	(414) Predictors of Survival to Discharge and Ventricular Recovery after VA-ECMO Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock J. A. Fried1, M. Cevasco2, L. Witer2, A. Masoumi1, D. Brodie3, J. Griffith1, V. Topkara1, K. Clerkin1, A. Zuver1, D. Karmpaliotis1, A. Kirtane1, H. Takayama2, M. Yuzefpolskaya1, Y. Naka2, P. Colombo1, K. Takeda2, A. R. Garan1. 1Cardiology, Columbia University Medical Center, New York, NY, 2Cardiothoracic Surgery, Columbia University Medical Center, New York, NY, 3Pulmonary and Critical Care Medicine, Columbia University Medical Center, New York, NY
7:05 PM	(415) Effect of Time from Cardiogenic Shock to Initiation of Complete Cardiovascular Support on Survival: "Shock to Support Time" A. Scatola1, A. Singh1, K. Singh2, N. Singh2, P. Meraj1. 1Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, 2New York Institute of Technology, New York, NY
7:10 PM	(416) Risk and Causes of 30-Day Readmissions Following Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock N. Tashtish1, S. Al-Kindi2, M. Karnib1, C. Di Felice3, E. Zanath4, G. Oliveira2, F. Lytle4, C. Elamm2. 1Internal Medicine, University Hosptials Cleveland Medical Center, Cleveland, OH, 2Cardiovascular Medicine, University Hosptials Cleveland Medical Center, Cleveland, OH, 3Pulmonary and Critical Care, University Hosptials Cleveland Medical Center, Cleveland, OH, 4Department of Anesthesia, University Hosptials Cleveland Medical Center, Cleveland, OH

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS
Secondary Audience: HF/HTX

Session Summary: The aim of this symposium is to update attendees on cutting edge techniques and experiences in the realm of ECMO, related both to BTT and non-BTT populations. Therapies and strategies that used to seem very isolated (mobilizing on ECMO, etc.) are likely more mainstream than previously thought. An understanding of the data and outcomes may lead to expanded international adoption of some useful practices.

Chairs: Feras Khaliel, MD, PhD and Ivan Knezevic, MD
 

7:00 AM	Pressure Volume Loops: What Insight Can They Give Us on Device Strategy? Navin K. Kapur, MD, Tufts Medical Center, Boston, MA, USA
7:15 AM	Q&A
7:20 AM	The Future of ECMO: It’s All About Hemocompatibility Omar Saeed, MD, Montefiore Medical Center, Bronx, NY, USA
7:35 AM	Q&A
7:40 AM	When the Bridge Has Termites: The Impact of ECMO-Related Infections on Post-Transplant Outcomes in Bridged Patients Priya Nair, MD, St Vincent's Hospital, Sydney, Australia
7:55 AM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS

Session Summary: This symposium will examine state of the art knowledge on device programming and medical management of LVAD patients. Current controversies such as the utility of platelet function monitoring and invasive hemodynamic testing will be reviewed and debated.

Chairs: Marco Masetti, MD, PhD, and Garrick C. Stewart, MD
 

8:00 AM	What are We Treating with Heart Failure Therapy after MCS: the LV, the RV, the Periphery or Ourselves? Gabriella Masciocco, MD, A.O. Niguarda Ca ' Granda, Milan, Italy
8:20 AM	Antiplatelet Therapy: Fixed Dose or Functional Assays? Jeffrey J. Teuteberg, MD, Stanford University School of Medicine, Stanford, CA, USA
8:35 AM	Time in Therapeutic Range: Is There an Optimal Way to Manage INR? Douglas L. Jennings, PharmD, New York-Presbyterian Hospital, New York, NY, USA
8:50 AM	Pump Data: Do We Need It to Decide Changes in Therapy? Thomas Schlöglhofer, MSc, Medical University of Vienna, Vienna, Austria
9:05 AM	DEBATE: You Need Information from Invasive Hemodynamics to Properly Manage an LVAD (PRO) Nir Uriel, MD, University of Chicago, Chicago, IL, USA
9:20 AM	DEBATE: You Need Information from Invasive Hemodynamics to Properly Manage an LVAD (CON) Emma Birks, MD, PhD, University of Louisville, Louisville, KY, USA
9:35 PM	10-min Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Sai Bhagra, MBBS and Erin Coglanese, MD
 

10:15 AM	(142) Understanding Risk Factors for Stroke Subtypes in the ENDURANCE Trials S. Cho1, R. Starling2, J. Teuteberg3, J. Rogers4, F. Pagani5, P. Shah6, K. Uchino7, T. Vassiliades8. 1John Hopkins University, Baltimore, MD, 2Cardiology, Cleveland Clinic, Cleveland, OH, 3Cardiology, Stanford University, Stanford, CA, 4Duke University, Durham, NC, 5University of Michigan, Ann Arbor, MI, 6Cardiology, Inova Fairfax, Falls Church, VA, 7Cleveland Clinic, Cleveland, OH, 8Medtronic, Framingham
10:30 AM	(143) Long-Term Burden of Hemocompatibility Related Adverse Events in the MOMENTUM 3 Trial: Final Analysis of the 1028 Patient Cohort N. Uriel1, M. Mehra2. 1University of Chicago, Chicago, IL, 2Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
10:45 AM	(144) Two-Year Outcomes in Real World Patients Treated with Heartmate 3TM Left Ventricular Assist Device for Advanced Heart Failure: Data from the ELEVATE Registry D. Saeed1, J. Garbade1, F. Gustafsson2, J. Lavee3, M. Morshuis4, D. Zimpfer5, E. Potapov6, Y. Pya7, J. Schmitto8, S. M. Shaw9. 1Department for Cardiac Surgery, Leipzig Heart Centre, Leipzig, Germany, 2The Heart Centre, Rigshospitalet, Copenhagen, Denmark, 3Heart Transplantation Unit, Leviev Heart Center, Tel Aviv, Israel, 4Department of Cardiothoracic Surgery, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany, 5Department of Surgery, Medical University of Vienna, Vienna, Austria, 6Deutsches Herzzentrum Berlin, Berlin, Germany, 7National Research Center for Cardiac Surgery, Astana, Kazakhstan, 8Medizinische Hochschule Hannover, Hannover, Germany, 9Heart and Lung Transplant Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom,
11:00 AM	(145) Impact of Stroke Onset Severity on 2-Year Survival in Destination Therapy Patients Supported by Centrifugal Flow versus Axial Flow Ventricular Assist Devices P. Shah1, C. Mahr2, J. Rogers3, M. Kiernan4, S. Boyce5, N. A. Mokadam6, F. Pagani7, T. Vassiliades8, J. Teuteberg9. 1Cardiology, Inova Fairfax, Falls Church, VA, 2Cardiology, University of Washington, Seattle, WA, 3Cardiology, Duke University, Durham, NC, 4Cardiology, Tufts University, Boston, MA, 5Cardiac Surgery, Washington Hospital Center, Washington, DC, 6Cardiac Surgery, University of Washington, Seattle, WA, 7Cardiac Surgery, University of Michigan, Ann Arbor, MI, 8Medtronic, Framingham, MA, 9Cardiology, Stanford University, Stanford, CA
11:15 AM	(146) Apixaban in HVAD Patients Non-Compliant to Standard Vitamin-K-Antagonism S. Schulte-Eistrup1, N. Mayer-Wingert1, N. Reiss2, J. Sindermann3, H. Warnecke1. 1Cardiac Surgery, Schuechtermann Klinik, Bad Rothenfelde, Germany, 2Clinical Research, Schuechtermann Klinik, Bad Rothenfelde, Germany, 3Rehabilitation, Schuechtermann Klinik, Bad Rothenfelde, Germany
11:30 AM	(147) Presence of Left Atrial or Left Ventricular Thrombus at the Time of CF-LVAD Implantation is Associated with Increased Post-Operative Risk of Stroke or Death J. A. Fried1, H. Lumish1, A. M. Zuver1, A. R. Garan1, V. K. Topkara1, B. Cagliostro1, G. Parkis2, M. Cevasco2, M. T. Pineda2, G. M. Mondellini1, K. Ross2, L. Witer2, H. Takayama2, K. Takeda2, Y. Naka2, M. Yuzefpolskaya1, R. T. Demmer3, P. C. Colombo1. 1Cardiology, Columbia University Medical Center, New York, NY, 2Department of Surgery, Columbia University Medical Center, New York, NY, 3Epidemiology and Community Health, University of Minnesota, Minneapolis, MN
11:45 AM	(148) Occurrence and Clinical Patterns of Stroke Based on Arterial Cannulation Strategy during Veno-Arterial Extracorporeal Membrane Oxygenation Support M. Nishikawa, J. Willey, A. R. Garan, M. Cevasco, L. Witer, J. Sanchez, P. Kurlansky, A. Kirtane, D. Brodie, M. Yuzefpolskaya, P. Colombo, H. Takayama, Y. Naka, K. Takeda. Columbia University Irving Medical Center, New York, NY

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: William Hiesinger, MD and J. Eduardo Rame, MD
 

10:15 AM	(149) Course and Clinical Impact of Tricuspid Regurgitation after LVAD Implantation: An Analysis of the EUROMACS Registry K. Veen1, M. M. Mokhles1, O. I. Soliman1, T. M. de By2, P. Mohacsi3, F. Schoenrath4, L. Paluszkiewicz5, A. J. Bogers1, J. J. Takkenberg1, K. Caliskan1. 1Erasmus MC, Rotterdam, Netherlands, 2EUROMACS Registry, Windsor, United Kingdom, 3University Hospital Zurich, Zurich, Switzerland, 4German Heart Centre Berlin, Berlin, Germany, 5Heart and Diabetes Centre NRW, Bad Oeynhausen, Germany
10:30 AM	(150) Aortic Insufficiency is Associated with Hemocompatibility-Related Adverse Events in LVAD Patients T. Imamura, J. Raikhelkar, G. Kim, B. Smith, S. Kalantari, A. Nguyen, N. Narang, B. Chung, I. Ebong, L. Holzhauser, J. Grinstein, D. Nitta, T. Fujino, C. Juricek, D. Rodgers, P. Combs, T. Song, T. Ota, V. Jeevanandam, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
10:45 AM	(151) Impact of Pre-Op Mitral Regurgitation Following Left Ventricular Assist Device Implant G. N. Coyan1, B. Pierce2, Z. Rhinehart2, F. Thoma3, W. Katz2, A. Kilic1, R. Kormos1, C. M. Sciortino1. 1Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, 2Cardiology, University of Pittsburgh, Pittsburgh, PA, 3Heart and Vascular Institute, University of Pittsburgh, Pittsburgh, PA,
11:00 AM	(152) Longitudinal Trend of Tricuspid Regurgitation Following Left Ventricular Assist Device Implantation T. Fujino, T. Imamura, D. Nitta, D. Rodgers, A. Nguyen, B. Chung, J. Raikhelkar, B. Smith, I. Ebong, N. Narang, L. Holzhauser, T. Ota, V. Jeevanandam, G. Kim, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
11:15 AM	(153) TAVI in LVAD Patients with Aortic Insufficiency M. N. Belkin, T. Imamura, A. J. Kanelidis, L. Holzhauser, I. Ebong, N. Narang, J. E. Blair, S. Nathan, J. D. Paul, A. P. Shah, B. Chung, A. Nguyen, B. Smith, S. Kalantari, J. Raikhelkar, N. Sarswat, G. Kim, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
11:30 AM	(154) Increased Incidence of De Novo Aortic Incompetence in Patients Supported with Impella Prior to LVAD Implantation S. D. Rao, B. Johnson, V. Medina, E. Rame, L. Goldberg, J. Wald, P. Atluri, C. Bermudez, M. Acker, E. Y. Birati. University of Pennsylvania, Philadelphia, PA
11:45 AM	(155) Impact of Concomitant Valvular Surgery on Patients Undergoing LVAD Implantation K. Y. Mulumba1, P. Kasinpila1, R. Fong1, S. Kong1, L. Hecker1, R. Nissan1, D. Banerjee2, J. Teuteberg2, Y. Shudo1, Y. Woo1, W. Hiesinger1. 1Cardiothoracic Surgery, Stanford University, Palo Alto, CA, 2Cardiology, Stanford University, Palo Alto, CA

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Nader Moazami, MD and Emma Birks, MD, PhD
 

1:45 PM	(168) Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: The RAMP-IT-UP Multicenter Study N. Uriel1, D. Burkhoff2, J. Rich3, S. Drakos4, D. Banerjee5, J. Teuteberg5, G. Sayer1. 1University of Chicago, Chicago, IL, 2Columbia University, New York, NY, 3Northwestern University, Chicago, IL, 4University of Utah, Salt Lake City, UT, 5Stanford University, Palo Alto, CA
2:00 PM	(169) HeartMate 3 Surgical Implant Technique and Outcomes in the MOMENTUM 3 Trial C. Salerno1, Y. Naka2, S. C. Silvestry3, D. J. Goldstein4, J. C. Cleveland5, A. Bansal6, N. A. Mokadam7, J. N. Schroder8, V. Jeevanandam9, A. J. Tatooles10, J. Chuang11, J. W. Long12. 1St. Vincent Heart Center, Indianapolis, IN, 2Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, NY, 3Florida Hospital, Orlando, FL, 4Montefiore Einstein Center for Heart and Vascular Care, New York, NY, 5University of Colorado School of Medicine, Aurora, CO, 6Ochsner Clinic Foundation, New Orleans, LA, 7Ohio State University Medical Center, Columbus, OH, 8Duke University Medical Center, Durham, NC, 9University of Chicago School of Medicine and Medical Center, Chicago, IL, 10Advocate Christ Medical Center, Oak Lawn, IL, 11Abbott, Abbott Park, IL, 12Integris Baptist Medical Center, Oklahoma City, OK
2:15 PM	(170) Poor Left Ventricular Unloading is Associated with Increased Mortality after Continuous Flow Left Ventricular Assist Device Implantation V. Maharaj1, R. Cogswell1, J. Schultz1, R. John2, C. Martin1, T. Thenappan1, T. Alexy1. 1Division of Cardiology, University of Minnesota Medical Center, Minneapolis, MN, 2Division of Cardiothoracic Surgery, University of Minnesota Medical Center, Minneapolis, MN
2:30 PM	(171) Effect of Anesthesia on Cardiac Hemodynamics in patients undergoing durable LVAD Implantation: The EACH LVAD Study T. C. Hanff1, P. A. Patel2, K. L. Kurcik1, S. Rao1, S. E. Kimmel3, M. E. Putt3, P. Atluri4, C. A. Bermudez4, M. A. Acker4, E. Y. Birati1, J. E. Rame1, J. W. Wald1. 1Division of Cardiology, University of Pennsylvania, Philadelphia, PA, 2Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 4Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, PA
2:45 PM	(172) Evaluation of Anticoagulation Bridging Strategies in LVAD Patients A. D. Rabon1, D. J. Taber2, W. E. Uber1, B. A. Houston3, H. Meadows1. 1Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, 2Department of Surgery, Medical University of South Carolina, Charleston, SC, 3Division of Cardiology, Medical University of South Carolina, Charleston, SC
3:00 PM	(173) Concentrated Factor Administration and Subsequent Pump Thrombosis on HeartMate II LVAD Support H. Shah1, R. Cogswell1, J. Misialek2, J. Schultz1, A. Nitzkowski3, R. John4, C. Martin1, M. Pritzker1, A. Shaffer4. 1Cardiology, University of Minnesota, Minneapolis, MN, 2Epidemiology & Community Health, University of Minnesota, Minneapolis, MN, 3Pharmacology, University of Minnesota, Minneapolis, MN, 4Cardiothoracic Surgery, University of Minnesota, Minneapolis, MN
3:15 PM	(174) Regional Outcomes after Continuous-Flow Left Ventricular Assist Device: An IMACS Analysis K. K. Mirza1, R. Rongbing Xie2, J. K. Kirklin2, B. Meyns3, J. A. Cowger4, J. Pennington2, F. Gustafsson1, D. Goldstein5. 1Department of Cardiology, Rigshospitalet, Copenhagen, Denmark, 2Department of Surgery, University of Alabama, Birmingham, AL, 3Katholieke Universiteit Leuven, Leuven, Belgium, 4Henry Ford Hospital, Detroit, MI, 5Department of Cardiothoracic Surgery, Montefiore Medical Center, Bronx, NY

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: NHSAH

Chairs: Gene H. Kim, MD and Mary E. Keebler, MD
 

1:45 PM	(175) Complete Sternal-Sparing LVAD Implantation is a Safe and Effective Technique for Obese Patients K. Wood, B. C. Ayers, H. Vidula, J. Alexis, B. Barrus, S. Prasad, I. Gosev. University of Rochester, Rochester, NY
2:00 PM	(176) Continuous-Flow Left Ventricular Assist Devices and Bariatric Surgery in Patients with Morbid Obesity and Heart Failure - A Systematic Review J. Challapalli1, D. Cross2, M. P. Weber2, J. Choi2, E. J. Maynes2, R. Aggarwal3, A. J. Boyle4, J. W. Entwistle2, H. T. Massey2, R. J. Morris2, V. Tchantchaleishvili2. 1College of Medicine, Drexel University, Philadelphia, PA, 2Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, PA, 3Department of Surgery, Thomas Jefferson University, Philadelphia, PA, 4Division of Cardiology, Thomas Jefferson University, Philadelphia, PA
2:15 PM	(177) Impact of Diabetes Mellitus on Mortality and In-Hospital Outcomes after Left Ventricular Assist Device Implantation V. Blumer1, M. Ortiz2, G. Hernandez3, S. Chaparro1, A. Vest4. 1University of Miami, Miami, FL, 2University of Iowa, Iowa, IA, 3Univ. of Miami, Miami, FL, 4Tufts Medical Center, Boston, MA
2:30 PM	(178) The Combination of Left Ventricular Assist Device and Laparoscopic Sleeve Gastrectomy May Promote Myocardial Recovery in Obese Advanced Chronic Heart Failure Patients G. Poglajen1, S. Kumar1, B. Akkanti1, R. Radovancevic1, S. Nathan1, M. Jumean1, M. H. Akay1, M. Patel1, B. Vrtovec2, B. Kar1, I. D. Gregoric1. 1Department of Advanced Cardiopulmonary Therapies and Transplantation, The Univ. of Texas Health Science Center-Houston, Houston, TX, 2Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Ljublijana, Slovenia
2:45 PM	(179) Comprehensive Nutrition Assessment before Left Ventricular Assist Device Implantation in Chronically Ill Hospitalized Patients A. Melehy, D. Seres, H. Mullen, J. Sanchez, P. Kurlanksy, R. Garan, V. Topkara, M. Yuzefpolskaya, P. C. Colombo, H. Takayama, Y. Naka, K. Takeda. Columbia University Medical Center, New York, NY
3:00 PM	(180) The Impact of Frailty on Survival in Patients Undergoing Advanced Therapies for Heart Failure M. Stein1, K. T. O'Brien1, F. Foroutan1, V. Rao1, H. J. Ross1, A. C. Alba2. 1Toronto General Hopsital, University Health Network, Toronto, ON, Canada, 2Toronto General Hospital, University Health Network, Toronto, ON, Canada
3:15 PM	(181) Frailty and Clinical Outcomes Following Left Ventricular Assist Device Implantation H. G. Uzun1, E. Demir2, E. Simsek2, T. Capanoglu3, H. Karapolat3, C. Engin4, T. Yagdi4, P. Ozturk4, M. Ozbaran4, S. Nalbantgil2. 1Cardiology, Can State Hospital, Canakkale, Turkey, 2Cardiology, Ege University, Izmir, Turkey, 3Physical Medicine and Rehabilitation, Ege University, Izmir, Turkey, 4Cardiovascular Surgery, Ege University, Izmir, Turkey

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: BSTR, PATH

Chairs: Ahmet Kilic, MD and Carlo Banfi, MD, PhD, FCCP
 

4:00 PM	(196) Evaluation of the Effect of Artificial Pulsatility in Continuous Flow Assist Device on Peripheral Vascular Reactivity P. Ivak1, J. Pi'ha2, P. Wohlfahrt2, I. Kralova-Lesna2, V. Lanska3, Z. Tucanova1, M. Konarik1, I. Netuka1. 1Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Laboratory for Atherosclerosis Research, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 3Department of Data Analysis and Statistics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
4:15 PM	(197) Long-Term Changes in Kidney Function after Left Ventricular Assist Device Implant: An Analysis of the STS Intermacs Database D. D. Franz1, M. R. Stedman1, S. L. Myers2, D. C. Naftel2, S. A. Silver3, D. Banerjee1, T. I. Chang1. 1Medicine, Stanford University, Palo Alto, CA, 2University of Alabama at Birmingham, Birmingham, AL, 3Kingston General Hospital, Kingston, ON, Canada
4:30 PM	(198) Functional Assessment of Decellularized Extracellular Matrix in Patients Undergoing LVAD Implantation D. Yu1, M. Vaicik2, A. Nguyen1, D. Rodgers1, N. Narang1, H. Holzhauser1, I. Ebong1, A. Kanelidis1, G. Sayer1, J. Raikhelkar1, N. Sarswat1, B. Smith1, S. Kalantari1, B. Chung1, J. Georgiadis2, N. Uriel1, G. H. Kim1. 1Department of Medicine, Section of Cardiology, University of Chicago, Chicago, IL, 2College of Engineering, Illinois Institute of Technology, Chicago, IL
4:45 PM	(199) Platelet Transcriptomics Following Mechanical Unloading A. Koliopoulou, C. Frey, E. Montenont, J. W. Rowley, S. H. McKellar, S. G. Drakos, M. T. Rondina, C. H. Selzman. University of Utah, Salt Lake City, UT
5:00 PM	(200) A Comparison of Middle Cerebral Artery and Central Retinal Artery Hemodynamics in HM II Patients E. J. Stöhr1, R. Ji2, K. Akiyama3, F. Castagna2, A. Pinsino2, J. R. Cockcroft1, M. Yuzefpolskaya2, A. R. Garan2, V. K. Topkara2, R. T. Te-Frey3, H. Takayama3, K. Takeda3, Y. Naka3, P. C. Colombo2, J. Z. Willey4, B. J. McDonnell1. 1Physiology & Health, Cardiff Metropolitan University, Cardiff, United Kingdom, 2Medicine, Columbia University Medical Center, New York, NY, 3Cardiothoracic Surgery, Columbia University Medical Center, New York, NY, 4Neurology Stroke, Columbia University Medical Center, New York, NY
5:15 PM	(201) Risk of dnDSA with Various MCS Devices as Bridge-to-Transplant R. T. Cole1, M. Flattery2, J. Minto3, A. Parikh4, T. Dong1, R. Roy1, L. Bogar5, A. Smith1, J. Vega1, A. Morris1, S. Laskar6, K. Bhatt1, D. Gupta1, A. Lala7, K. Shah8, P. Shah9. 1Cardiology, Emory Univ Sch of Med, Atlanta, GA, 2Cardiology, Virginia Commonwealth University, Richmond, VA, 3George Washington University School of Medicine, Washington, D.C., DC, 4Cardiology, Mount Sinai Hospital, New York, NY, 5Department of Cardiac Surgery, Inova Heart and Vascular Institute, Falls Church, VA, 6Cardiology, Emory University School of Medicine, Atlanta, GA, 7Mount Sinai Hospital, New York, NY, 8Virginia Commonwealth University, Richmond, VA, 9Inova Heart and Vascular Institute, Falls Church, VA
5:30 PM	(202) Associations among Biomarkers of Congestion, Inflammation and Oxidative Stress in Heart Failure, LVAD and Heart Transplant E. A. Royzman1, G. M. Mondellini1, A. M. Zuver1, C. A. Bravo2, D. L. Brunjes1, D. Onat1, M. Mabasa1, J. C. Hupf1, A. R. Garan1, H. Takayama3, K. Takeda3, Y. Naka3, R. T. Demmer4, P. C. Colombo1, M. Yuzefpolskaya1. 1Department of Medicine, Columbia University Medical Center, New York, NY, 2Department of Medicine, Montefiore Medical Center, Bronx, NY, 3Department of Surgery, Columbia University Medical Center, New York, NY, 4Epidemiology and Community Health, University of Minnesota, Minneapolis, MN

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS

Session Summary: Following a brief update on the state of the art of short and long term MCS, this symposium will focus on innovation and improvement opportunities. Specifically, issues of device size, deployment / implantation, hemodynamic properties and hemocompatibility will be reviewed. Presenters will discuss current capabilities as well as ongoing research and development efforts with 2- and 5-year targets. This symposium is not CME accredited.

Chairs: Ulrich Jorde, MD and Simon Maltais, MD, PhD
 

4:00 PM	STATE OF THE ART Durable MCS and Unmet Needs Joseph G. Rogers, MD, Duke University Medical Center, Durham, NC, USA
4:05 PM	The Future of Durable MCS - Medtronic Perspective Eric Corndorf, PhD, Medtronic, Framingham, MA, USA
4:20 PM	The Future of Durable MCS - Abbott Perspective Kevin Bourque, DVP, Abbott, Burlington, MA, USA
4:35 PM	STATE OF THE ART and Unmet Needs Total Heart Replacement (THR) Julia Riebandt, MD, Medical University of Vienna, Vienna, Austria
4:40 PM	The Future of THR - Syncardia Perspective Steven R. Langford, BSEE, SynCardia Systems, Tucson, AZ, USA
4:55 PM	The Future of THR - Carmat Perspective Piet G. Jansen, MD, PhD, Carmat SA, Velizy-Villacoublay Cedex, France
5:10 PM	STATE OF THE ART Acute MCS and Unmet Needs Shelley Hall, MD, Baylor University Medical Center, Dallas, TX, USA
5:15 PM	The Future of Acute MCS - Abiomed Perspective Daniel H. Raess, MD, FACC, FACS, Abiomed, Danvers, MA, USA
5:30 PM	Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Mechanical Circulatory Support (Adult) (Timor Sea 1)
(MCS)   Poster Numbers: 890-943
 

---

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Mechanical Circulatory Support (Adult) (Timor Sea 2)
(MCS)   Poster Numbers: 854-889, 1100

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Antonio Loforte, MD and Sanem Nalbantgil, MD
 

6:00 PM	(453) Early Anticoagulation Bridging to Therapeutic International Normalized Ratio after Left Ventricular Assist Device Implantation is Not Associated with Thromboembolic and Bleeding Complications: A Systematic Review and Meta-Analysis V. Kittipibul1, N. Angsubhakorn2, J. Kewchareon3, N. Prasitlumkum3, P. Rattanawong3. 1Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, 2Department of Internal Medicine, University of Minnesota, Minneapolis, MN, 3Department of Internal Medicine, University of Hawaii, Honolulu, HI
6:05 PM	(454) Thalidomide Use Reduces Risk of Refractory Gastrointestinal Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices P. Namdaran1, T. A. Zikos2, J. Y. Pan2, D. Banerjee3. 1Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT, 2Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, 3Division of Cardiovascular Medicine, Stanford University, Stanford, CA
6:10 PM	(917) HVAD Cannula Positioning is Associated with Higher GI Bleed Rates T. Imamura, G. Kim, J. Raikhelkar, B. Smith, A. Nguyen, N. Narang, B. Chung, I. Ebong, L. Holzhauser, D. Nitta, T. Fujino, C. Juricek, P. Combs, T. Song, T. Ota, V. Jeevanandam, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
6:15 PM	(456) Diagnostic Yield of Endoscopy Procedures in the Management of Left Ventricular Assist Device Recipients Presenting with Gastrointestinal Bleeding A. Y. Lee1, K. M. Tecson2, H. E. Sheffield3, M. E. Marcom3, A. Z. Jacob3, S. Patlolla4, N. H. Kwak5, B. L. Da6, J. Felius7, S. A. Hall8, H. Kale9, P. Kale8. 1Baylor Heart and Vascular Hospital, Dallas, TX, 2Baylor Heart and Vascular Institute, Baylor Scott & White Research Institute, Dallas, TX, 3College of Medicine, Texas A&M Health Science Center, Dallas, TX, 4Department of Internal Medicine, Baylor Scott and White, Dallas, TX, 5Department of Gastroenterology, SUNY Health Science Center, Brooklyn, NY, 6National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD, 7Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, TX, 8Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott and White, Dallas, TX, 9Digestive Health Associates of Texas, Baylor Scott and White, Dallas, TX
6:20 PM	(457) Serotonergic Antidepressants and Hospitalization for Bleeding in Patients with LVAD K. Behrend1, M. P. Lillyblad1, P. Skelton1, R. F. Gaberich2, K. Wilson2, P. M. Eckman3, B. Sun3, K. Hryniewicz3. 1Abbott Northwestern Hospital, Minneaplis, MN, 2Minneapolis Heart Institute Foundation, Minneaplis, MN, 3Minneapolis Heart Institute, Minneaplis, MN
6:25 PM	(458) Correlation of Thromboelastography Parameters with Bleeding Episodes of Post-LVAD Surgery P. Tantrachoti, P. Pachariyanon, W. Vutthikraivit, B. Hirsch, N. Nair. Texas Tech University Health Sciences Center, Lubbock, TX
6:30 PM	(459) Safety and Performance of a Self-Assembling Peptide Haemostat for the Management of Bleeding after Left Ventricular Assist Device Implantation: Outcomes of a Post Market Clinical Follow-Up Study M. Morshuis, M. Schönbrodt, J. Gummert. Cardiac Surgery, HDZ-NRW.de, Bad Oeynhausen, Germany
6:35 PM	(460) Pre-Operative Ventilatory Inefficiency is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices M. D. Yu1, J. Newman1, Y. Brailovsky1, M. Liebo1, R. Zolty2, B. Lowes2, A. Heroux1, E. Raichlin1. 1Loyola University Medical Center, Maywood, IL, 2University of Nebraska Medical Center, Omaha, NE
6:40 PM	(461) Pulmonary Artery Pulsatile Index (PAPi) Score May Predict Risk of Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device L. Cunningham, S. George, A. M. El Banayosy, D. Horstmanshof. Advanced Heart Failure and Transplant Cardiology, Integris Baptist Medical Center, Oklahoma City, OK
6:45 PM	(462) Gastrointestinal Hemorrhage among LVAD Recipients. A Nationwide Inpatient Sample Study D. C. Voruganti1, G. P. Shantha2, C. Inampudi3, P. Alvarez3, M. C. Giudici3, A. Briasoulis3. 1Internal Medicine, University of Iowa Hospitals and Clincs, Iowa City, IA, 2Cardiovascular Diseases, University of Michigan, Ann Arbor, MI, 3Cardiovascular Diseases, University of Iowa Hospitals and Clincs, Iowa City, IA
6:50 PM	(463) Microbiome-Derived TMAO Exhibits No Protective Effect against GIB in LVAD Patients A. M. Zuver1, K. L. Hoffman2, D. D'Angelo2, D. Onat1, E. A. Royzman1, J. C. Hupf1, D. L. Brunjes1, G. M. Mondellini1, C. A. Bravo3, M. Tiburcio4, A. R. Garan1, H. Takayama4, K. Takeda4, Y. Naka4, P. C. Colombo1, R. T. Demmer5, M. Yuzefpolskaya1. 1Department of Medicine, Columbia University Medical Center, New York, NY, 2Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, 3Department of Medicine, Montefiore Medical Center, Bronx, NY, 4Department of Surgery, Columbia University Medical Center, New York, NY, 5Epidemiology and Community Health, University of Minnesota, Minneapolis, MN
6:55 PM	(464) Gastrointestinal Bleeding Ceases after Heart Transplantation in Patients Bridged on Continuous-Flow LVAD Support A. Critsinelis1, J. Kraus2, H. Lamba1, F. Cheema1, A. Civitello1, R. Delgado1, A. Nair1, A. Shafii1, G. Loor1, T. Rosengart1, O. Frazier1, J. Morgan1. 1Division of Cardiothoracic Transplantation and Mechanical Circulatory Support, Texas Heart Institute at Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, TX

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS
Secondary Audience: BSTR, PATH

Session Summary: Mechanical unloading of the left ventricle is a potent platform through which to study reverse remodeling. While we now understand that sufficient “recovery” to allow for device explantation is realistic in only a select population, the concept of reverse remodeling during LVAD still has much broader application. This symposium will highlight reverse remodeling during MCS starting with basic physiology and moving through clinical topics and commencing with a view to the future.

Chairs: Ivan Netuka, MD, PhD and Joyce W. Wald, DO
 

7:00 AM	Cardiac Recovery on Acute Mechanical Support - When to Wean and When to Transition Anna L. Meyer, MD, Leipzig Heart Center, Leipzig, Germany
7:15 AM	Q&A
7:20 AM	LVAD Explantation for Cardiac Recovery – Who, When, and How Snehal R. Patel, MD, Montefiore Medical Center, Bronx, NY, USA
7:35 AM	Q&A
7:40 AM	Present and Future of Cardiac Recovery and Durable MCS Stavros G. Drakos, MD, PhD, FACC, University of Utah School of Medicine, Salt Lake City, UT, USA
7:55 AM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: NHSAH

Chairs: Stuart D. Russell, MD and Finn Gustafsson, MD, PhD
 

10:30 AM	(238) Sequential Chains of Adverse Events Post LVAD Implantation F. Movahedi1, R. L. Kormos2, L. Lohmueller3, L. Seese2, M. Kanwar4, S. Murali5, Y. Zhang6, R. Padman7, J. F. Antaki8. 1Electrical Engineering, University of Pittsburgh, Pittsburgh, PA, 2Medicine, Heart and Vascular Institute, Pittsburgh, PA, 3School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, 4Electrical Engineering, Cardiovascular Institute at Allegheny General Hospital, Pittsburgh, PA, 5Cardiovascular Institute at Allegheny General Hospital, Pittsburgh, PA, 6Weill Cornell Medicine, Pittsburgh, NY, 7Heinz College of Information Systems and Public Policy, Pittsburgh, PA, 8Meinig School of Biomedical Engineering, Cornell University, Pittsburgh, PA
10:45 AM	(239) VE/VCO2 Predicts RV Dysfunction and Mortality after Left Ventricular Assist Device: A Fresh Look at Cardiopulmonary Stress Testing for Prognostication J. Grinstein1, Y. Sawalha2, M. Hofmeyer1, F. Sheikh1, M. Rodrigo1, A. Kadakkal1, C. Barnett1, S. Kalantari3, I. Talati4, R. Zaghlol2, E. Molina1, S. Mohammed1, S. Najjar1. 1MedStar Heart and Vascular Institute, Washington, DC, 2MedStar Washington Hospital Center, Washington, DC, 3University of Chicago, Chicago, IL, 4Georgetown University School of Medicine, Washington, DC
11:00 AM	(240) Features for Success: Factors Associated with Successful LVAD Outcomes at 1-Year Post Implant L. C. Lohmueller1, M. Kanwar2, S. Murali2, J. F. Antaki3. 1Language Technologies Institute, Carnegie Mellon University, Pittsburgh, PA, 2Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA, 3Biomedical Engineering, Cornell University, Ithaca, NY
11:15 AM	(241) Derivation and Validation of the EUROMACS Left Ventricular Assist Device Score for Long-Term Outcome - The EUROMACS-LVAD-Score B. Schrage1, N. Rübsamen2, C. Magnussen1, J. Gummert3, F. Schönrath4, T. de By5, B. Meyns6, D. Westermann1, S. Blankenberg1, H. Reichenspurner1, A. Bernhardt1. 1University Heart Center Hamburg, Hamburg, Germany, 2University Heart Centre Hamburg, Hamburg, Germany, 3Heart and Diabetes Center Bad Oeynhausen, Bad Oeynhausen, Germany, 4German Heart Center Berlin, Berlin, Germany, 5EUROMACS, Windsor, United Kingdom, 6Cardiale Heelkunde, Leuven, Belgium
11:30 AM	(242) A Novel Model Incorporating Pectoralis Muscle Measures to Predict Mortality after Ventricular Assist Device Implantation R. Cogswell1, T. Murray2, R. Araujo3, L. Teigen1, B. Trachtenberg3, J. Schultz1, R. John4, C. Martin1, J. Estep5. 1Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, MN, 2School of Public Health, Department of Biostatistics, University of Minnesota, Minneapolis, MN, 3Department of Medicine, Division of Cardiology, Houston Methodist, Houston, TX, 4Department of Surgery, Division of Cardiovascular Surgery, University of Minnesota, Minneapolis, MN, 5Department of Medicine, Division of Cardiology, Cleveland Clinic, Cleveland, OH
11:45 AM	(243) Heart Failure Severity Stratification beyond INTERMACS Profiles: A Step towards Identification of Optimal LVAD Implantation Timing R. Cogswell1, J. Estep2, R. Araujo3, L. Teigen1, J. Schultz1, R. John4, C. Martin1, B. Trachtenberg3. 1Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, MN, 2Department of Medicine, Division of Cardiology, Cleveland Clinic, Cleveland, OH, 3Department of Medicine, Division of Cardiology, Houston Methodist, Houston, TX, 4Department of Surgery, Division of Cardiovascular Surgery, University of Minnesota, Minneapolis, MN
12:00 PM	(244) Geriatric Nutrition Risk Index is Associated with LVAD Recipient Survival with Cutoff Value of 92.68 M. Kawabori1, S. Lofftus2, A. Vest1, V. Pramil2, Y. Zhan1, K. G. Warner1, H. Rastegar1, M. S. Kiernan1, F. Y. Chen1, G. S. Couper1. 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: PHARM

Chairs: Jan F. Gummert, MD, PhD and Gabriel Sayer, MD
 

2:00 PM	(252) High Afterload Driving Poor Cardiac Output in LVAD Patients is Rectified with Nitrate Therapy A. Rosenbaum, A. Behfar. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN
2:15 PM	(253) Intravenous Iron Replacement in Patients with Left Ventricular Assist Devices. A Pilot Study A. Mardis1, C. Robinson2, B. Stafford2, J. Patel1, J. Barham2, A. Poole2, S. Branham2, J. Martin2, R. Napier3, P. McCann3. 1Department of Pharmacy, Palmetto Health, Columbia, SC, 2Cardiothoracic Surgery, Palmetto Health, Columbia, SC, 3Cardiology, Palmetto Health, Columbia, SC
2:30 PM	(254) A Trial of Complete Withdrawal of Anticoagulation Therapy in the Heartmate 3 Pump I. Netuka1, P. Ivak1, Z. Tucanova1, S. Gregor1, O. Szarszoi1, J. Rimsans2, J. Connors2, D. Crandall3, P. Sood3, M. Mehra2. 1Institute for Clinical & Experimental Medicine, Prague, Czech Republic, 2Brigham and Women’s Hospital, Boston, MA, 3Abbott, Burlington, MA
2:45 PM	(255) A Long-Term Counterpulsation Heart Assist System Used as a Bridge to Decision in Advanced Congestive Heart Failure T. Symalla1, T. Song1, D. Onsager1, T. Ota1, C. LaBuhn1, P. Combs1, T. Lammy1, S. Patel-Raman2, G. Sayer3, G. Kim3, J. Raikhelkar3, N. Uriel3, V. Jeevanandam1. 1Cardiac Surgery, University of Chicago, Chicago, IL, 2NuPulseCV, University of Chicago, Chicago, IL, 3Cardiology, University of Chicago, Chicago, IL
3:00 PM	(256) Calculation of VAD Cardiac Cycle Volume Using HeartWare Waveform K. L. Kiehl1, B. N. Butzler1, M. T. Saltzberg2, D. Ishizawar2, A. A. Mohammed2, R. L. Kursel2, N. A. Gaglianello2. 1Advanced Heart Failure, Froedtert Hospital, Milwaukee, WI, 2Advanced Heart Failure and Transplant Cardiology, The Medical College of Wisconsin, Milwaukee, WI
3:15 PM	(257) Right Heart Function Worsens in LVAD Patients with Decoupling between Pulmonary Artery and Wedge Pressures> T. Imamura, B. Smith, J. Raikhelkar, D. Rodgers, G. Kim, S. Kalantari, A. Nguyen, N. Narang, B. Chung, I. Ebong, L. Holzhauser, D. Nitta, T. Fujino, C. Juricek, P. Combs, D. Onsager, T. Song, T. Ota, V. Jeevanandam, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
3:30 PM	(258) Outcomes of Obese Patients Bridged to Heart Transplantation with Continuous-Flow Left Ventricular Assist Devices A. K. Okoh1, S. Fugar2, M. Schulthies3, M. Russo1, K. Rivandra1, R. Yanagida1, M. Camacho1. 1RWJ Barnabas Health Newark Beth Israel Medical Center, RWJ Barnabas Health Newark Beth Israel Medical Center, Newark, NJ, 2Division of Cardiology, Rush University Medical Center, Chicago, NJ, 3RWJ Barnabas Health Newark Beth Israel Medical Center, Neward, NJ

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: MCS
Secondary Audience: NHSAH

Session Summary: Patient and healthcare provider partnerships can enhance patient outcomes. Remote care support and monitoring of MCS patients can improve patient independence and positively impact patient care. This joint symposium with the International Consortium of Circulatory Assist Clinicians (ICCAC) will discuss integration of self-care strategies, educational preparation, new technologies maximizing MCS patient management, strategies to reduce morbidity and mortality, the future of MCS support, and challenges and opportunities that advancing technology poses to current practice.

Chairs: Peggy S. Blood, RN, MSN and Simon Maltais, MD, PhD
 

2:00 PM	Under Pressure: Continuous Pulmonary Artery Monitoring and LVAD Finn Gustafsson, MD, PhD, Rigshospitalet, Copenhagen, Denmark
2:15 PM	Q&A
2:20 PM	Care Anywhere: Remote Patient Monitoring Michele C. Kassemos, BSN, UCSF Medical Center, San Francisco, CA, USA
2:25 PM	Q&A
2:40 PM	There's an App for That: Preparing the EMS Thomas Schloeglhofer, MSc, Medical University of Vienna, Vienna, Austria
2:55 PM	Q&A
3:00 PM	Frailty and Exercise Tolerance: How Are They Related? Kavitha Muthiah, MBchB, PhD, St. Vincent's Hospital, Sydney, Australia
3:15 PM	Q&A
3:20 PM	Let the Pacer Do the Work! Conduction Abnormalities in Heart Failure and Their Role in Exercise During VAD Support Van-Khue Ton, MD, PhD, University of Maryland School of Medicine, Baltimore, MD, USA
3:35 PM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Ioannis Dimarakis, PhD, FRCS and Amanda R. Vest, MBBS, MPH
 

4:15 PM	(280) Hemodynamic and ECHO Measurements during VA ECMO Weaning Suggest Acceptable LV Unloading A. M. El Banayosy, C. Gordon, M. M. Koerner, M. D. Harper, D. Horstmanshof, D. Vanhooser, J. W. Long, A. El Banayosy. INTEGRIS Baptist Medical Center, Oklahoma City, OK
4:30 PM	(281) Predicting Cardiac Recovery before Durable Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients I. Taleb1, B. D. Horne2, M. Yin1, J. Nativi-Nicolau1, O. Wever-Pinzon1, S. McKellar1, W. T. Caine2, A. Koliopoulou1, R. Alharethi2, A. Kfoury2, E. M. Gilbert1, J. C. Fang1, J. Stehlik1, C. H. Selzman1, S. G. Drakos1. 1University of Utah, Salt Lake City, UT, 2Intermountain Medical Center, Salt Lake City, UT
4:45 PM	(282) Does Indication for LVAD at Time of Implant Matter in Younger Patients? A. Lala1, J. Rowland1, A. Gelijns2, E. Bagiella2, A. Moskowitz2, B. Ferket1, S. Pinney3, M. Miller4, F. Pagani5, D. Mancini6. 1Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, 2Population Health Science, Icahn School of Medicine at Mount Sinai, New York, NY, 3Medicine, Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, 4NHLBI, Bethesda, MD, 5Cardiothoracic Surgery, University of Michigan, Ann Arbor, NY, 6Medicine, Cardiology, Population Health Science, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY
5:00 PM	(283) Cardiac Reverse Remodeling and Recovery in Dilated Cardiomyopathy Medication-Naive Patients Requiring Durable Left Ventricular Assist Device Support I. Taleb1, M. Yin1, A. Koliopoulou1, M. Taleb1, E. Dranow1, L. Kemeyou1, W. T. Caine2, O. Wever-Pinzon1, R. Alharethi2, A. G. Kfoury2, J. Nativi-Nicolau1, J. C. Fang1, J. Stehlik1, C. H. Selzman1, S. G. Drakos1. 1University of Utah, Salt Lake City, UT, 2Intermountain Medical Center, Salt Lake City, UT
5:15 PM	(284) Normalization of Metabolic Status after LVAD Implantation is Associated with Heart Failure Free Survival A. Nguyen, T. Imamura, B. Chung, L. Holzhauser, N. Narang, D. Rodgers, B. Smith, J. Raikhelkar, D. Onsager, T. Song, C. Juricek, T. Ota, V. Jeevanandam, G. Kim, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
5:30 PM	(285) Baseline ECHO a Suitable Screening Tool for LV Recovery during CF LVAD Support S. Rangasamy, O. Saeed, D. B. Sims, J. Shin, S. Murthy, S. Vukelic, D. Goldstein, U. Jorde, S. R. Patel. Cardiology, Montefiore Medical Center, Bronx, NY
5:45 PM	(286) Long-Term Outcome of Patients after Successful LVAD Explant: A EUROMACS Study C. Antonides1, F. Schoenrath2, K. Veen1, R. Muslem1, I. Netuka3, J. Gummert4, B. Meyns5, M. Özbaran6, D. Schibilsky7, T. de By8, K. Caliskan9. 1Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands, 2Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany, DZHK (German Center for Cardiovascular Research), partner site, Berlin, Germany, 3Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 4Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center, NRW, Ruhr University Bochum, Bad Oeynhausen, Germany, 5Department of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium, 6Department of Cardiovascular Surgery, Ege Üniversitesi Tıp Fakültesi, Izmir, Turkey, 7Department of Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg - Bad Krozingen, Freiburg, Germany, 8EACTS, EUROMACS, Windsor, United Kingdom, 9Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: EEP

Chairs: Minoru Ono, MD, PhD and Ivan Knezevic, MD
 

4:15 PM	(287) Predictors and Impact of Vasoplegia after Continuous-Flow Left Ventricular Assist Device Implantation M. Kim, H. Lamba, R. Miller, J. George, S. Sattee, F. Cheema, A. Civitello, R. Delgado, A. Nair, A. Shafii, G. Loor, T. Rosengart, O. Frazier, J. Morgan, S. Chatterjee. Division of Cardiothoracic Transplantation and Mechanical Circulatory Support, Texas Heart Institute at Baylor College of Medicine, Houston, TX
4:30 PM	(288) Longitudinal Trends in Gut Microbial Community Diversity among HF Patients Undergoing LVAD M. Yuzefpolskaya1, B. Bohn D.F.2, D. Onat1, A. Zuver1, D. L. Brunjes1, E. A. Royzman1, A. Pinsino3, K. L. Antler1, J. C. Hupf1, M. B. Dominguez1, A. R. Garan4, H. Takayama5, K. Takeda5, Y. Naka5, P. C. Colombo1, R. T. Demmer6. 1Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, 2Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, 3Medicine, Jacobi AECOM, Bronx, New York, NY, 4Medicine, Division of Cardiology, Columbia University, New York, NY, 5Surgery, Columbia University Medical Center, New York, NY, 6Epidemiology and Community Health, University of Minnesota, Minneapolis, MN
4:45 PM	(289) Novel Approach to Assess Intraventricular Pressure Difference in Patients with Left Ventricular Assist Device during Ramp Study K. Akiyama1, E. J. Stöhr2, R. Ji3, O. G. Jimenez4, I. Wu5, K. Itatani6, S. Miyazaki7, T. Furusawa7, T. Nishino7, B. J. McDonnell8, A. R. Garan3, M. Yuzefpolskaya3, P. C. Colombo3, Y. Naka1, H. Takayama1, K. Takeda1. 1Cardiothoracic Surgery, Columbia University Medical Center, New York, NY, 2Cardiac Physiology and Health, Cardiff Metropolitan University, Cardiff, United Kingdom, 3Cardiology, Columbia University Medical Center, New York, NY, 4Surgery, Columbia University Medical Center, New York, NY, 5Anesthesiology, Columbia University Medical Center, New York, NY, 6Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan, 7Cardio Flow Design, Tokyo, Japan, 8Cardiff Metropolitan University, Cardiff, United Kingdom
5:00 PM	(290) Post-Implant Phosphodiesterase-5 Inhibitor Use is Associated with Increased Rates of Late Right Heart Failure after LVAD: An INTERMACS Analysis  E. Grandin1, G. Gulati2, K. Kennedy3, F. Cabezas1, E. Y. Birati4, J. Rame4, P. Atluri5, F. D. Pagani6, J. K. Kirklin7, D. C. Naftel7, R. L. Kormos8, J. Teuteberg9, M. Kiernan2. 1Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, 2Division of Cardiovascular Medicine, Tufts Medical Center, Boston, MA, 3BIDMC Smith Center for Outcomes Research in Cardiology, St. Luke's Mid-America Heart Institute, Kansas City, MO, 4Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 5Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, MA, 6Division of Cardiothoracic Surgery, University of Michigan, Ann Arbor, MI, 7Division of Cardiothoracic Surgery, University of Alabama Birmingham, Birmingham, AL, 8Division of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 9Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA
5:15 PM	(291) Hemodynamic Evaluation of Right Ventricular Function before and after Impella 5.0 Placement for Cardiogenic Shock  A. M. Wolfson, R. M. Cole, D. Emerson, J. Moriguchi, J. S. Chung, D. Ramzy. Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
5:30 PM	(292) Does Low-Intensity Anticoagulation Using Vitamin K Antagonists Correlate with Factor X Activity Inpatients Implanted with the HeartMate 3 Pump? A Validation Analysis of the MAGENTUM 1 Study J. M. Connors1, I. Netuka2, P. Ivák3, Z. Tučanová3, S. Gregor4, P. Sood5, D. Crandall6, M. R. Mehra7. 1Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 2Institute for Clinical & Experimental Medicine, Prague, Czech Republic, 3Department of Cardiovascular Surgery, Institute for Clinical & Experimental Medicine, Prague, Czech Republic, 4Department of Pharmacy, Institute for Clinical & Experimental Medicine, Prague, Czech Republic, 5Global Clinical Affairs, Heart Failure, Abbott, Burlington, MA, 6Global Clinical, Heart Failure, Abbott, Burlington, MA, 7Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
5:45 PM	(293) Impact of Socioeconomic Status on Outcomes Post-Ventricular Assist Device Implantation J. J. Han1, A. Iyengar1, W. L. Patrick1, J. Goldenring2, M. Molina1, A. Ameer1, M. Helmers1, E. Y. Birati3, P. Atluri1. 1Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 2Perelman School of Medicine, Philadelphia, PA, 3Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Mechanical Circulatory Support (Adult) (Timor Sea 1)
(MCS)   Poster Numbers: 1116-1169
 

---

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Mechanical Circulatory Support (Adult) (Timor Sea 2)
(MCS)   Poster Numbers: 1064-1115

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Snehal Patel, MD and Josef Stehlik, MD, MPH
 

6:15 PM	(561) Unexpected Contribution of Pulsatility to Pump Thrombosis J. Engelman, K. Muthiah, P. Jain, D. Robson, P. Jansz, C. Hayward. Heart Failure and Transplant Unit, St Vincent's Hospital, Sydney, Australia
6:20 PM	(562) CCR5 Expression is Lower in Women, and Mediates Sex-Based Differences in Post-LVAD Right Ventricular Failure A. Nayak1, A. A. Morris1, C. M. Sciortino2, C. Neill3, R. L. Kormos2, C. McTiernan4, J. Larsen3, T. N. Bachman4, K. Hanley-Yanez4, D. M. McNamara2, M. A. Simon2. 1Emory University, Atlanta, GA, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3University of Pittsburgh School of Medicine, Pittsburgh, PA, 4University of Pittsburgh Vascular Medicine Institute, Pittsburgh, PA
6:25 PM	(563) Impact of Left Ventricular Assist Device Placement on Chronic Kidney Diseases: A Multicenter Longitudinal Study Y. C. Yalcin1, R. Muslem1, K. Veen1, R. J. Tedford2, B. Tomashitis2, Y. Al Najam1, A. Kilic3, B. Houston2, J. J. Brugts1, A. C. Constantinescu1, O. C. Manintveld1, S. Hsu4, A. J. Bogers1, K. Caliskan1. 1Thoraxcenter, Erasmus University, Rotterdam, Netherlands, 2Cardiology, University of South Carolina, Charleston, SC, 3Cardiothoracic Sugery, Johns Hopkins School of Medicine, Baltimore, MD, 4Cardiology, Jonhs Hopkins School of Medicine, Baltimore, MD
6:30 PM	(564) Elevated Shear Associated with MCS Devices Yields Unique Platelet Membrane Lipid Species: Pro-Thrombotic Agonists? A. Sweedo1, L. M. Wise2, Y. Roka-Moiia3, J. Sheriff4, D. Bluestein4, J. G. Purdy2, M. J. Slepian3. 1Biomedical Engineering, University of Arizona, Tucson, AZ, 2Immunobiology, University of Arizona, Tucson, AZ, 3Medicine, University of Arizona, Tucson, AZ, 4Biomedical Engineering, Stony Brook University, Stony Brook, NY
6:35 PM	(565) Time-Dependent Association of Renal Function with Long-Term Survival Following LVAD Implantation H. Vidula, S. McNitt, M. Wang, S. Polonsky, S. Sherazi, I. Gosev, B. Ayers, K. Wood, B. Barrus, J. Alexis, L. Chen, V. Kutyifa, I. Goldenberg. Univ of Rochester, Rochester, NY
6:40 PM	(566) Metabolic Vasoreactivity in the Middle Cerebral Artery of Heart Failure Patients with and without Continuous-Flow Left Ventricular Support R. Ji1, K. Akiyama2, F. Castagna1, A. Pinsino1, J. R. Cockcroft3, M. Yuzefpolskaya1, A. Garan1, V. K. Topkara,1, M. T. Pineda4, H. Takayama4, K. Takeda4, Y. Naka4, P. C. Colombo1, B. McDonnell3, E. J. Stöhr3, J. Z. Willey5. 1Medicine, Columbia University Medical Center, New York, NY, 2Surgery, Columbia University Medical Center, New York, NY, 3Physiology & Health, Cardiff Metropolitan University, Cardiff, CF5 2YB, United Kingdom, 4Cardiothoracic Surgery, Columbia University Medical Center, New York, NY, 5Neurology Stroke, Columbia University Medical Center, New York, NY
6:45 PM	(567) Incidence and Predictors of Long-Term Renal Function Deterioration after Implantation of a Centrifugal, Continuous-Flow Device for Bridge to Transplant N. Kikuchi, A. Yoshimura, H. Hattori, A. Suzuki, T. Shiga, H. Niinami, N. Hagiwara, S. Nunoda. Tokyo Women's Medical University, Tokyo, Japan
6:50 PM	(568) Baseline LVAD Flow is an Important Risk for Hemoresponse to Blood Stream Infection in LVAD Patients with Fixed Cardiac Output N. Bart1, S. Emmanuel2, D. Andresen3, K. Muthiah1, C. S. Hayward1. 1Heart Transplant and Failure, St Vincents Hospital, Sydney, Australia, 2Cardiothoracic Surgery, St Vincents Hospital, Sydney, Australia, 3Infectious Disease, St Vincents Hospital, Sydney, Australia
6:55 PM	(569) What Happens to Right Ventricular Strain and Function Following Tricuspid Valve Repair in Patients Undergoing Implantation of a Left Ventricular Assist Device? O. N. Kislitsina1, A. S. Anderson1, J. D. Thomas1, J. D. Rich1, J. E. Wilcox1, E. E. Vorovich1, A. Zhou2, A. C. Andrei3, R. Harap1, P. M. McCarthy4, C. W. Yancy1, D. T. Pham4. 1Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2CTU, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Cardiac Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL
7:00 PM	(570) Cystatin C is Superior to Creatinine for Prediction of Adverse Events in Heart Failure Patients Undergoing LVAD Implant A. Pinsino1, A. Gaudig2, E. A. Royzman2, M. B. Dominguez2, J. Radhakrishnan2, K. Toma2, A. M. Zuver2, M. Tiburcio3, V. Topkara2, A. Masoumi2, A. R. Garan2, H. Takayama3, K. Takeda3, Y. Naka3, R. T. Faillace1, R. T. Demmer4, P. C. Colombo2, M. Yuzefpolskaya2. 1Medicine, Jacobi AECOM, Bronx, NY, 2Department of Medicine, Columbia University Medical Center, New York, NY, 3Department of Surgery, Columbia University Medical Center, New York, NY, 4Epidemiology and Community Health, University of Minnesota, Minneapolis, MN
7:05 PM	(571) Trends and Predictors of Acute Kidney Injury in Patients with and without Chronic Kidney Disease Undergoing Left Ventricular Assist Device Implantation: A Nationwide Inpatient Sample Analysis S. Ranka1, M. Pahuja2, S. Mony3, T. Akhtar1, O. Chahab2, H. Abubakar4, A. Yassen2, T. Ando2, P. Alvarez5, L. Afonso2, A. Brisoulis5. 1John H Stroger Hospital of Cook County, Chicago, IL, 2Detroit Medical Center Wayne State University, Detroit, MI, 3University of South Florida, Tampa, FL, 4Detroit Medical Center Wayne State University, Chicago, IL, 5University of Iowa, Iowa City, IA
7:10 PM	(572) Advanced Kidney Disease in the Left Ventricular Assist Device Population: Impact on Disease Progression, Morbidity and Mortality J. Grinstein, A. Kadakkal, M. Rodrigo, M. Hofmeyer, S. Mohammed, P. E. Craig, R. Torguson, E. Molina, S. Najjar, F. Sheikh. MedStar Heart and Vascular Institute, Washington, DC

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Cristiano Amarelli, MD and Pavan Atluri, MD
 

6:15 PM	(549) Home Inotropic Therapy Post Left Ventricular Assist Device Placement S. Pauwaa, K. Meehan, L. Kukla, N. Krause, T. Aicher, G. Macaluso, A. Andrade, A. Joshi, C. Sciamanna, M. Dia, P. Pappas, A. Tatooles, W. Cotts. Advocate Christ Medical Center, Oak Lawn, IL
6:20 PM	(550) The Effect of Right Ventricular Arterial Uncoupling on Mortality in Cardiogenic Shock V. Nguyen1, J. McCabe1, C. Mahr1, T. Jones2, M. Tan3, R. Cheng1, T. Dardas1, S. Masri1. 1Department of Medicine, Division of Cardiology, University of Washington, Seattle, WA, 2Department of Medicine, Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT, 3Department of Medicine, University of Washington, Seattle, WA
6:25 PM	(1119) The Model for End-Stage Liver Disease Score and Survival after the Total Artificial Heart A. Jahangiri1, M. Smallfield1, A. Andreae2, K. Desai2, T. Johnson3, J. Hillaryd3, E. Sawey1, J. Cook4, D. Tang1, V. Kasirajan1, K. B. Shah1. 1Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, 2Virginia Commonwealth University School of Medicine, Richmond, VA, 3Internal Medicine, Virginia Commonwealth University, Richmond, VA, 4Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, Nashville, TN
6:30 PM	(552) Timing of Right Heart Failure after Left Ventricular Assist Device is Associated with Survival after Heart Transplantation E. M. Senser1, F. Cabezas2, E. W. Grandin2. 1Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, 2Cardiology, Beth Israel Deaconess Medical Center, Boston, MA
6:35 PM	(1117) Relationship between Length of Hospital Stay Post LVAD Implant and Survival: The Potential for Understanding a Less Sick Population S. Silvestry1, J. Rogers2, W. Cotts3, M. Slaughter4, S. Prasad5, M. Jacoski6, F. Pagani7, L. Stein8. 1Cardiac Surgery, Florida Hospital Transplant Hospital, Orlando, FL, 2Cardiology, Duke University, Durham, NC, 3Cardiology, Advocate Christ Medical Center, Oak Lawn, IL, 4Cardiac Surgery, University of Louisville, Louisville, KY, 5Cardiac Surgery, University of Rochester, Rochester, NY, 6Medtronic, Framingham, MA, 7Cardiac Surgery, University of Michigan, Ann Arbor, MI, 8Cardiac Surgery, SUNY Downstate, Brooklyn, NY
6:40 PM	(1118) Safety of Mechanical Circulatory Support for Left Ventricular Non-Compaction: Single Center Experience A. Bansal1, F. Akhtar1, M. Bansal2, S. Desai3, D. Jacks1, Y. Gilliland3. 1Cardiothoracic Surgery, Ochsner Clinic Foundation, New Orleans, LA, 2Pathology, Ochsner Clinic Foundation, New Orleans, LA, 3Heart Transplant Med, Ochsner Clinic Foundation, New Orleans, LA
6:45 PM	(895) Tricuspid Regurgitation Predicts Late Onset Right Heart Failure after Left Ventricular Assist Device Implantation O. Gonzalez Fernandez, N. Bouzas Cruz, C. Ferrera Duran, A. Woods, N. Robinson-Smith, S. Tovey, G. Parry, K. Booth, G. MacGowan, S. Schueler. Freeman Hospital, Newcastle upon Tyne, United Kingdom
6:50 PM	(556) Utilization of Combined Mechanical Circulatory Support Devices in Cardiogenic Shock: Insights from the National Inpatient Sample M. Pahuja1, S. Ranka2, S. Mony3, O. Chahab4, T. Ando4, H. Abubakar4, A. Yassen4, P. Alvarez5, L. Afonso6, A. Brisoulis5. 1Detroit Medical Center/Wayne State University, Detroit, ME, 2John H Stroger Hospital of Cook County, Chicago, IL, 3University of South Florida, Tampa, FL, 4Detroit Medical Center Wayne State University, Detroit, MI, 5University of Iowa, Iowa City, IA, 6Detroit Medical Center/Wayne State University, Detroit, MI
6:55 PM	(557) Temporary Mechanical Circulatory Support, a New Paradigm in Bridging Patients to Heart Transplantation: Comparing Outcomes versus Durable Left Ventricular Assist Devices J. S. Chung, D. Emerson, D. Ramzy, A. Akhmerov, R. M. Cole, D. Megna, F. Esmailian, J. Moriguchi, J. A. Kobashigawa, A. Trento. Cedars-Sinai Medical Center, Los Angeles, CA
7:00 PM	(558) Temporary Mechanical Circulatory Support as a Bridge to Heart Transplantation: Insights from the UNOS Database A. K. Okoh1, S. Fugar2, M. Schulthies3, M. Russo1, R. Karanam1, M. Zucker1, R. Yanagida1, M. Camacho1. 1RWJ Barnabas Health Newark Beth Israel Medical Center, RWJ Barnabas Health Newark Beth Israel Medical Center, Newark, NJ, 2Division of Cardiology, Rush University Medical Center, Chicago, IL, 3RWJ Barnabas Health Newark Beth Israel Medical Center, Newark, NJ
7:05 PM	(559) Novel Percutaneous Dual Lumen Cannula Right Ventricular Assist Device Provides Effective Support for Patients after Left Ventricular Assist Device Implantation M. Salna, A. R. Garan, A. Kirtane, D. Karmpaliotis, P. Green, T. Vahl, H. Takayama, J. Sanchez, P. Kurlansky, M. Yuzefpolskaya, P. C. Colombo, Y. Naka, K. Takeda. Columbia University Medical Center, New York, NY
7:10 PM	(560) Direct Cavo-Pulmonary Stent Mounted Right Ventricular Assist Device J. Park, P. Bonde. Yale School of Medicine, New Haven, CT

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Emil Najjar, MD and Ulrich Jorde, MD
 

10:15 AM	(308) Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices J. Axelrad1, A. S. Faye2, A. Pinsino3, B. Cagliostro3, A. Thanataveerat4, L. Effner3, F. M. Pineda3, A. R. Garan3, H. Takayama5, K. Takeda5, Y. Naka5, P. C. Colombo3, T. Gonda2, M. Yuzefpolskaya3. 1Gastroenterology, NYU Langone, NYC, NY, 2Gastroenterology, Columbia University Medical Center, NYC, NY, 3Cardiology, Columbia University Medical Center, NYC, NY, 4Biostatistics, Columbia University Medical Center, NYC, NY, 5CT Surgery, Columbia University Medical Center, NYC, NY
10:30 AM	(309) Hemocompatibility Related Outcomes of Centrifugal and Axial Flow LVADs: An IMACS Registry Analysis S. J. Forest, Y. Xia, O. Saeed, S. Patel, U. Jorde, D. J. Goldstein. Montefiore Medical Center, Bronx, NY
10:45 AM	(310) Promising Novel Treatment with Intravenous Bevacizumab for Refractory Gastrointestinal Bleeding from Angiodysplastic Lesions in Patients Supported with a Continuous-Flow Left Ventricular Assist Device: A Pilot Study R. Asleh, S. D. Schettle, S. Maltais, R. C. Daly, V. Iyer, J. M. Stulak, R. Rodeheffer. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
11:00 AM	(311) Prediction of GIB Using R2 CHA2DS2 VASc Risk Score A. Critsinelis1, H. Lamba1, S. Chatterjee1, F. Cheema1, A. Civitello1, R. Delgado1, A. Nair1, A. Shafii2, G. Loor1, T. Rosengart1, O. Frazier1, J. Morgan1. 1Division of Cardiothoracic Transplantation and Mechanical Circulatory Support, Texas Heart Institute at Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, TX
11:15 AM	(312) Experimental Venous Congestion Causes Peripheral Release of Angiopoietin-2 and Tissue Necrosis Factor-α - A New Insight into the Pathophysiology of Gastrointestinal Bleeding in CF-LVAD Patients P. C. Colombo1, F. Castagna1, D. Onat1, S. M. Lagana2, W. Y. Ka1, E. A. Royzman1, A. S. Faye3, J. E. Axelrad4, T. A. Gonda3, A. R. Garan5, H. Takayama6, K. Takeda6, Y. Naka6, G. Parkis7, M. Yuzefpolskaya1, R. Demmer8. 1Cardiology, Columbia University Medical Center, New York, NY, 2Pathology & Cell Biology, Columbia University Medical Center, New York, NY, 3Digestive & Liver Diseases, Columbia University Medical Center, New York, NY, 4Gastroenterology, New York University, New York, NY, 5Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, 6Surgery, Columbia University Medical Center, New York, NY, 7Columbia University Medical Center, New York, NY, 8Epidemiology and Community Health, University of Minnesota, Minneapolis, MN,
11:30 AM	(313) Digoxin Restores Angiogenic Equilibrium in CF- LVAD Patients S. Vukelic1, S. Patel1, P. Vlismas1, T. Chinnadurai1, D. Sims1, S. Murthy1, J. Shin1, O. Saeed1, N. Sibinga2, S. Forest3, D. Goldstein3, U. Jorde1. 1Cardiology, Montefiore MC AECOM, New York, NY, 2Cardiology, AECOM, New York, NY, 3Cardiothoracic & Vascular Surgery, Montefiore MC AECOM, New York, NY
11:45 AM	(314) Gastrointestinal Angiodysplasia is Part of the Vascular Pathophysiology of Advanced Heart Failure S. R. Patel, S. Vukelic, J. Kwah, T. Chinnadurai, O. Saeed, D. Goldstein, U. P. Jorde. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: NHSAH

Chairs: Ivan Knezevic, MD and Jose Gonzalez-Costello, MD
 

12:15 PM	(350) Routine Right Heart Catheterization in LVAD Patients Awaiting Heart Transplant: What is the Appropriate Surveillance Interval? D. Ruan1, M. Farr2, V. Topkara2, A. R. Garan2, J. Sanchez1, P. Kurlansky3, M. Yuzefpolskaya2, P. Colombo2, H. Takayama4, Y. Naka4, K. Takeda4. 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 3Department of Surgery, Columbia University Irving Medical Center, New York, NY, 4Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY
12:30 PM	(351) Cardiac and Cerebrovascular Response to Exercise in the Setting of Mechanical Circulatory Support among Individuals with Advanced Heart Failure T. Tran1, G. Coe1, M. Bradley1, K. O'Gean1, M. Spotts1, M. Ostertag1, S. Laing1, L. C. Prado1, C. Cornwell2, J. Paul1, W. Cornwell1. 1University of Colorado, Aurora, CO, 2Ohio State University, Columbus, OH
12:45 PM	(352) Echocardiographic Predictors of Left Ventricle Unloading after LVAD Implantation A. Duran, A. Guha, A. Bhimaraj, J. Estep, B. Trachtenberg, M. H. Park, N. Salam, F. Hussain, I. Hussain. Houston Methodist Hospital, Houston, TX
1:00 PM	(353) Comparison of Exercise Hemodynamics in Patients Supported with Centrifugal and Axial Flow Left Ventricular Assist Devices N. Moss1, A. Parikh1, V. Rakita2, A. Lala1, S. Mitter1, J. Roldan1, A. Cuca1, M. Barghash1, J. Contreras1, S. Pinney1, A. Anyanwu1, D. M. Mancini1. 1Mount Sinai Hospital, New York, NY, 2Temple University Hospital, Philadelphia, PA
1:15 PM	(354) High Right Ventricular Afterload is Associated with Impaired Exercise Tolerance in LVAD Patients V. Ton1, L. Dees1, E. Sorensen1, E. Feller1, R. Madathil1, D. Kaczorowski1, B. Griffith1, R. J. Tedford2, G. Ramani1. 1University of Maryland School of Medicine, Baltimore, MD, 2Medical University of South Carolina, Charleston, SC
1:30 PM	(355) Exercise-Induced Hypoxemia Predicts Heart Failure Hospitalization and Death in Patients Supported with Left Ventricular Assist Devices D. M. Koerber1, A. N. Rosenbaum2, T. P. Olson2, S. Kushwaha2, J. Stulak3, S. Maltais3, A. Behfar1. 1Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, 2Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 3Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN
1:45 PM	(356) Prospective Evaluation of LVAD Risk Scores’ Capacity to Predict Cardiopulmonary Exercise Parameters A. Dorken1, P. Öztürk2, E. Demir3, Ç. Engin2, S. Nalbantgil3, T. Yağdi2, M. Özbaran2. 1Ege University Faculty of Medicine, Izmir, Turkey, 2Cardiovascular Surgery, Ege University Faculty of Medicine, Izmir, Turkey, 3Cardiology, Ege University Faculty of Medicine, Izmir, Turkey